RSNA 2014 

Abstract Archives of the RSNA, 2014


RC116A

Drug Development and Clinical Trial Basics

Refresher/Informatics

Presented on November 30, 2014
Presented as part of RC116: Imaging in Therapeutic and Diagnostic Agent Development

Participants

Andrea Marie Perrone MD, Presenter: Employee, Merck & Co, Inc

LEARNING OBJECTIVES

1) Understand the phases of drug development adn the key players in the process. 2) Understandn the concepts behind trial endpoints, particularly endpoints in which imaging is used. 3) Recognize the distinct applications of radiology at the various stages of drug development and in various medical specialty areas.

ABSTRACT

The process of drug devleopment is a critical feature of the landscape of modern medicine.  Radiology can play a variety of roles in the development of therapeutic agents, and the involvement of radiology and radiologists in this process will be the focus of this course.  Topics will include the drug approval process and key players, trial design and endpoints, and how image interpretation for clinical trials is distinct from typical clinical reads.  Additionally, the course will discuss the process of development for diagnostic agents, such as contrast materials and PET tracers.

Cite This Abstract

Perrone, A, Drug Development and Clinical Trial Basics.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002207.html